Dr. Agha Zeeshan Mirza PhD (University of Karachi); Visiting Researcher (Purdue University)
Manager, Macter International, Karachi · Pakistan
Editorial leadership for Journal of New Developments in Chemistry ISSN 2377-2549
Research interests
- Pharmaceutical Chemistry
- Synthesis Of Derivatives
- Complexes Of Drugs
- Analytical Chemistry
- Nano Chemistry
Biography
Dr. Agha Zeeshan Mirza serves as Manager at Macter International in Karachi, Pakistan, having completed his PhD with educational training at the University of Karachi and Purdue University. His research focuses on pharmaceutical analysis and drug characterization, encompassing the development of analytical methods for various therapeutic agents, spectroscopic studies of drug interactions, and computational approaches to drug design. Dr. Mirza has authored over 16 indexed publications, with his most influential work examining the role of PPAR receptors in disease and their ligands, which has garnered 479 citations since its publication in 2019. His methodological contributions span RP-HPLC, spectrophotometric techniques, and stability-indicating assays for diverse pharmaceutical compounds and formulations.
Selected publications
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications 2019 cited 479×
- Emulgel: an effective drug delivery system 2021 cited 81×
- Dihydrofolate reductase, thymidylate synthase, and serine hydroxy methyltransferase: successful targets against some infectious diseases 2022 cited 39×
- Bilayer tablets: A developing novel drug delivery system 2020 cited 29×
- Simultaneous Determination of Chloroquine and Pyrimethamine with Cetirizine in an Active Form and Human Serum by RP-HPLC 2021 cited 12×
- Fabrication and characterization of doxorubicin functionalized PSS coated gold nanorod 2019 cited 9×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JNDC for your work?
This journal is guided by Dr. Agha Zeeshan Mirza (Manager, Macter International, Karachi) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.